Loading...

MTBC

Nasdaq:MTBC
Snowflake Description

Flawless balance sheet and fair value.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
MTBC
Nasdaq
$61M
Market Cap
  1. Home
  2. US
  3. Healthcare
Company description

MTBC, Inc., a healthcare information technology company, provides an integrated suite of Web-based solutions and related business services to healthcare providers primarily in the United States. The last earnings update was 15 days ago. More info.


Add to Portfolio Compare Print
MTBC Share Price and Events
7 Day Returns
2.4%
NasdaqGM:MTBC
1.3%
US Healthcare Services
0.2%
US Market
1 Year Returns
50.6%
NasdaqGM:MTBC
29.6%
US Healthcare Services
2.9%
US Market
MTBC Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
MTBC (MTBC) 2.4% -5.2% 13.6% 50.6% 465.6% -
US Healthcare Services 1.3% 8.5% 12% 29.6% 72.2% 58.6%
US Market 0.2% -1.6% 2.4% 2.9% 36.1% 41%
1 Year Return vs Industry and Market
  • MTBC outperformed the Healthcare Services industry which returned 29.6% over the past year.
  • MTBC outperformed the Market in United States of America which returned 2.9% over the past year.
Price Volatility
MTBC
Industry
5yr Volatility vs Market

Value

 Is MTBC undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of MTBC to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for MTBC.

NasdaqGM:MTBC Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 3 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 9.9%
Perpetual Growth Rate 10-Year US Government Bond Rate 2.7%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for NasdaqGM:MTBC
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year US Govt Bond Rate 2.7%
Equity Risk Premium S&P Global 6%
Healthcare Services Unlevered Beta Simply Wall St/ S&P Global 1.23
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 1.229 (1 + (1- 21%) (7.43%))
1.202
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.2
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.73% + (1.202 * 5.96%)
9.89%

Discounted Cash Flow Calculation for NasdaqGM:MTBC using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for MTBC is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

NasdaqGM:MTBC DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 9.89%)
2019 11.18 Est @ 92.72% 10.18
2020 18.53 Est @ 65.72% 15.34
2021 27.21 Est @ 46.82% 20.50
2022 36.35 Est @ 33.6% 24.92
2023 45.20 Est @ 24.34% 28.20
2024 53.27 Est @ 17.85% 30.24
2025 60.36 Est @ 13.32% 31.18
2026 66.48 Est @ 10.14% 31.25
2027 71.74 Est @ 7.92% 30.69
2028 76.31 Est @ 6.36% 29.71
Present value of next 10 years cash flows $252.22
NasdaqGM:MTBC DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= $76.31 × (1 + 2.73%) ÷ (9.89% – 2.73%)
$1,094.26
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $1,094.26 ÷ (1 + 9.89%)10
$425.98
NasdaqGM:MTBC Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $252.22 + $425.98
$678.20
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $678.20 / 12.03
$56.38
NasdaqGM:MTBC Discount to Share Price
Calculation Result
Value per share (USD) From above. $56.38
Current discount Discount to share price of $5.09
= -1 x ($5.09 - $56.38) / $56.38
91%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price MTBC is available for.
Intrinsic value
>50%
Share price is $5.09 vs Future cash flow value of $56.38
Current Discount Checks
For MTBC to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • MTBC's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • MTBC's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for MTBC's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are MTBC's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NasdaqGM:MTBC PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-03-31) in USD $-0.68
NasdaqGM:MTBC Share Price ** NasdaqGM (2019-05-22) in USD $5.09
United States of America Healthcare Services Industry PE Ratio Median Figure of 13 Publicly-Listed Healthcare Services Companies 58.29x
United States of America Market PE Ratio Median Figure of 3,085 Publicly-Listed Companies 17.79x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of MTBC.

NasdaqGM:MTBC PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NasdaqGM:MTBC Share Price ÷ EPS (both in USD)

= 5.09 ÷ -0.68

-7.46x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • MTBC is loss making, we can't compare its value to the US Healthcare Services industry average.
  • MTBC is loss making, we can't compare the value of its earnings to the United States of America market.
Price based on expected Growth
Does MTBC's expected growth come at a high price?
Raw Data
NasdaqGM:MTBC PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -7.46x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 3 Analysts
60%per year
United States of America Healthcare Services Industry PEG Ratio Median Figure of 12 Publicly-Listed Healthcare Services Companies 2.38x
United States of America Market PEG Ratio Median Figure of 2,123 Publicly-Listed Companies 1.54x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for MTBC, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on MTBC's assets?
Raw Data
NasdaqGM:MTBC PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-03-31) in USD $3.08
NasdaqGM:MTBC Share Price * NasdaqGM (2019-05-22) in USD $5.09
United States of America Healthcare Services Industry PB Ratio Median Figure of 35 Publicly-Listed Healthcare Services Companies 4.61x
United States of America Market PB Ratio Median Figure of 5,201 Publicly-Listed Companies 1.84x
NasdaqGM:MTBC PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NasdaqGM:MTBC Share Price ÷ Book Value per Share (both in USD)

= 5.09 ÷ 3.08

1.65x

* Primary Listing of MTBC.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • MTBC is good value based on assets compared to the US Healthcare Services industry average.
X
Value checks
We assess MTBC's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare Services industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare Services industry average (and greater than 0)? (1 check)
  5. MTBC has a total score of 3/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is MTBC expected to perform in the next 1 to 3 years based on estimates from 3 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
60%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is MTBC expected to grow at an attractive rate?
  • Unable to compare MTBC's earnings growth to the low risk savings rate as it is expected to be loss making during the next 1-3 years.
Growth vs Market Checks
  • Unable to compare MTBC's earnings growth to the United States of America market average as it is expected to be loss making during the next 1-3 years.
  • MTBC's revenue growth is expected to exceed the United States of America market average.
Annual Growth Rates Comparison
Raw Data
NasdaqGM:MTBC Future Growth Rates Data Sources
Data Point Source Value (per year)
NasdaqGM:MTBC Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 3 Analysts 60%
NasdaqGM:MTBC Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 3 Analysts 9.8%
United States of America Healthcare Services Industry Earnings Growth Rate Market Cap Weighted Average 25.4%
United States of America Healthcare Services Industry Revenue Growth Rate Market Cap Weighted Average 11.6%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 13.7%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.3%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NasdaqGM:MTBC Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 3 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NasdaqGM:MTBC Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2020-12-31 69 -2 3
2019-12-31 64 -5 3
NasdaqGM:MTBC Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-03-31 57 7 -8
2018-12-31 51 7 -7
2018-09-30 42 6 -6
2018-06-30 33 3 -4
2018-03-31 32 2 -5
2017-12-31 32 0 -8
2017-09-30 32 -2 -11
2017-06-30 30 -1 -11
2017-03-31 28 -1 -10
2016-12-31 24 -1 -10
2016-09-30 21 0 -6
2016-06-30 21 -1 -6

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • MTBC is not considered high growth as it is expected to be loss making for the next 1-3 years.
  • MTBC's revenue is expected to grow by 9.8% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NasdaqGM:MTBC Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 3 Analyst Estimates (S&P Global) See Below

All data from MTBC Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqGM:MTBC Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2020-12-31 -0.09 -0.08 -0.09 2.00
2019-12-31 -0.44 -0.36 -0.54 3.00
NasdaqGM:MTBC Past Financials Data
Date (Data in USD Millions) EPS *
2019-03-31 -0.68
2018-12-31 -0.59
2018-09-30 -0.48
2018-06-30 -0.37
2018-03-31 -0.47
2017-12-31 -0.69
2017-09-30 -1.02
2017-06-30 -1.07
2017-03-31 -1.03
2016-12-31 -0.95
2016-09-30 -0.63
2016-06-30 -0.59

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if MTBC will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess MTBC's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
MTBC has a total score of 1/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has MTBC performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare MTBC's growth in the last year to its industry (Healthcare Services).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • MTBC does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare MTBC's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare MTBC's 1-year growth to the US Healthcare Services industry average as it is not currently profitable.
Earnings and Revenue History
MTBC's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from MTBC Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqGM:MTBC Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-03-31 57.32 -8.05 19.25 1.03
2018-12-31 50.55 -6.96 17.63 1.03
2018-09-30 42.33 -5.57 15.44 1.01
2018-06-30 32.80 -4.32 12.42 0.99
2018-03-31 31.90 -5.39 12.38 1.06
2017-12-31 31.81 -7.60 12.81 1.08
2017-09-30 32.35 -10.89 13.28 1.17
2017-06-30 30.18 -10.98 13.15 1.10
2017-03-31 27.60 -10.32 13.30 0.99
2016-12-31 24.49 -9.55 13.21 0.90
2016-09-30 21.03 -6.33 11.61 0.74
2016-06-30 21.30 -5.84 11.92 0.73
2016-03-31 22.05 -5.87 12.28 0.69
2015-12-31 23.08 -4.89 12.29 0.66
2015-09-30 24.82 -4.88 12.57 0.62
2015-06-30 25.22 -6.49 13.18 0.62
2015-03-31 21.87 -5.29 11.43 0.58
2014-12-31 18.30 -4.51 9.49 0.53
2014-09-30 14.18 -3.42 7.83 0.49
2014-06-30 11.12 -0.78 5.41 0.43
2014-03-31 10.81 -0.58 5.00 0.41
2013-12-31 10.47 -0.18 4.71 0.39
2013-09-30 9.91 -0.21 4.61 0.39
2012-12-31 10.02 0.12 4.54 0.40

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if MTBC has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if MTBC has efficiently used its assets last year compared to the US Healthcare Services industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if MTBC improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess MTBC's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare Services industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
MTBC has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is MTBC's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up MTBC's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • MTBC is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • MTBC's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of MTBC's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 5.3x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from MTBC Company Filings, last reported 1 month ago.

NasdaqGM:MTBC Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-03-31 37.01 4.55 12.53
2018-12-31 38.87 0.50 14.47
2018-09-30 27.27 0.64 1.26
2018-06-30 29.12 0.22 11.72
2018-03-31 20.68 0.20 3.54
2017-12-31 20.25 0.29 4.36
2017-09-30 16.57 2.38 2.79
2017-06-30 11.28 9.89 5.81
2017-03-31 4.23 13.34 1.25
2016-12-31 7.07 14.05 3.48
2016-09-30 11.07 9.85 7.11
2016-06-30 11.35 9.74 6.62
2016-03-31 12.82 9.79 7.37
2015-12-31 14.89 7.98 8.04
2015-09-30 10.58 5.75 1.61
2015-06-30 11.66 3.66 0.63
2015-03-31 13.10 3.86 1.19
2014-12-31 14.32 2.33 1.05
2014-09-30 15.13 2.54 2.49
2014-06-30 -0.38 3.23 0.03
2014-03-31 24.12 2.99 5.59
2013-12-31 0.12 3.56 0.50
2013-09-30 0.02 4.27 0.93
2012-12-31 0.41 1.60 0.27
  • MTBC's level of debt (12.3%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (12.5% vs 12.3% today).
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Whilst loss making MTBC has sufficient cash runway for more than 3 years if it maintains the current positive free cash flow level.
  • Whilst loss making MTBC has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by -109.2% per year.
X
Financial health checks
We assess MTBC's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. MTBC has a total score of 6/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is MTBC's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from MTBC dividends.
If you bought $2,000 of MTBC shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate MTBC's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate MTBC's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NasdaqGM:MTBC Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 3 Analyst Estimates (S&P Global) See Below
Global Healthcare Services Industry Average Dividend Yield Market Cap Weighted Average of 14 Stocks 1.3%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 2005 Stocks 2.5%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.4%
United States of America Top 25% Dividend Yield 75th Percentile 3.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

NasdaqGM:MTBC Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2020-12-31
2019-12-31

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as MTBC has not reported any payouts.
  • Unable to verify if MTBC's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of MTBC's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as MTBC has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess MTBC's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can MTBC afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. MTBC has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of MTBC's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Stephen Snyder
COMPENSATION $902,963
AGE 41
TENURE AS CEO 1.3 years
CEO Bio

Mr. Stephen A. Snyder has been Chief Executive Officer of Medical Transcription Billing, Corp since January 2018. Mr. Snyder served as the President of Medical Transcription Billing, Corp. since September 2011 to January 1, 2018. Mr. Snyder served as the Chief Operating Officer of Medical Transcription Billing, Corp from January 2009 to August 2011. Mr. Snyder joined Medical Transcription Billing, Corp. in September 2005 as a Vice President and General Counsel. Mr. Snyder served as an attorney with a New Jersey law firm. He has been a Director at Medical Transcription Billing, Corp. since 2013. He is a member of the New Jersey and New York bars, the American Health Lawyers Association and the American Trial Lawyers Association and his writings on healthcare law and practice management have been published in print and electronic media by the American Health Lawyers Association, American Bar Association and various industry publications. Mr. Snyder received his Bachelor of Arts in Political Science magna cum laude from Montclair State University and received his Juris Doctorate from Rutgers School of Law - Newark, where he served as a senior editor of a law journal.

CEO Compensation
  • Stephen's compensation has increased whilst company is loss making.
  • Stephen's remuneration is higher than average for companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the MTBC management team in years:

1.3
Average Tenure
50
Average Age
  • The average tenure for the MTBC management team is less than 2 years, this suggests a new team.
Management Team

Mahmud Haq

TITLE
Founder & Executive Chairman
COMPENSATION
$867K
AGE
59

Stephen Snyder

TITLE
CEO & Director
COMPENSATION
$903K
AGE
41
TENURE
1.3 yrs

Bill Korn

TITLE
Chief Financial Officer
COMPENSATION
$721K
AGE
61
TENURE
5.8 yrs

A. Chaudhry

TITLE
President & Director
AGE
41
TENURE
1.3 yrs

Norman Roth

TITLE
Principal Accounting Officer & Controller
AGE
62

Shruti Patel

TITLE
General Counsel & Corporate Secretary
AGE
30
TENURE
2.5 yrs

Rachel Grossinger

TITLE
Marketing Manager

Loraine Goetsch

TITLE
Division President

Ryan Howard

TITLE
Special Adviser to Chief Executive Officer
TENURE
1.1 yrs
Board of Directors Tenure

Average tenure and age of the MTBC board of directors in years:

5.4
Average Tenure
64
Average Age
  • The tenure for the MTBC board of directors is about average.
Board of Directors

Mahmud Haq

TITLE
Founder & Executive Chairman
COMPENSATION
$867K
AGE
59
TENURE
18.3 yrs

Stephen Snyder

TITLE
CEO & Director
COMPENSATION
$903K
AGE
41
TENURE
6.3 yrs

Howard Clark

TITLE
Vice Chairman & Director
COMPENSATION
$147K
AGE
74
TENURE
0.1 yrs

A. Chaudhry

TITLE
President & Director
AGE
41
TENURE
0.1 yrs

Cameron Munter

TITLE
Director
COMPENSATION
$137K
AGE
64
TENURE
5.9 yrs

John Daly

TITLE
Director
COMPENSATION
$137K
AGE
80
TENURE
5.4 yrs

Anne Busquet

TITLE
Director
COMPENSATION
$137K
AGE
68
TENURE
4.8 yrs
Who owns this company?
Recent Insider Trading
  • MTBC insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
30. Mar 19 Sell John Daly Individual 28. Mar 19 28. Mar 19 -10,000 $4.52 $-45,200
30. Mar 19 Sell A. Chaudhry Individual 29. Mar 19 29. Mar 19 -17,935 $4.44 $-79,631
30. Mar 19 Sell Shruti Patel Individual 28. Mar 19 28. Mar 19 -10,750 $4.50 $-48,375
29. Nov 18 Sell Stephen Snyder Individual 27. Nov 18 28. Nov 18 -27,005 $5.04 $-136,097
12. Sep 18 Sell Shruti Patel Individual 10. Sep 18 12. Sep 18 -12,291 $4.70 $-56,643
12. Sep 18 Buy Shruti Patel Individual 10. Sep 18 10. Sep 18 4,791 $4.52 $21,655
22. Aug 18 Sell John Daly Individual 20. Aug 18 20. Aug 18 -10,000 $4.70 $-47,000
X
Management checks
We assess MTBC's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. MTBC has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

What Kind Of Share Price Volatility Should You Expect For MTBC, Inc. (NASDAQ:MTBC)?

In finance, Beta is a measure of volatility. … Beta is a widely used metric to measure a stock's exposure to market risk (volatility). … Before we go on, it's worth noting that Warren Buffett pointed out in his 2014 letter to shareholders that 'volatility is far from synonymous with risk.' Having said that, beta can still be rather useful.

Simply Wall St -

Company Info

Description

MTBC, Inc., a healthcare information technology company, provides an integrated suite of Web-based solutions and related business services to healthcare providers primarily in the United States. The company operates through two segments, Healthcare IT and Practice Management. It primarily offers PracticePro, a software-as-a-service platform, which includes practice management software and related tools that facilitate the day-to-day business operation and workflows; electronic health record (EHR), which enables customers to reduce paperwork; revenue cycle management services, such as end-to-end medical billing, analytics, and related services; and mobile health solutions, including smartphone applications that assist patients and healthcare providers in the provision of healthcare services. The company also provides a Web-based EHR solution; healthcare claims clearinghouse services; transcription, coding, indexing, and other ancillary services; electronic data interchange services; and talkEHR, a voice enabled EHR solution. It serves physicians, nurses, nurse practitioners, physician assistants, and other clinical staff that render bills for their services. The company was formerly known as Medical Transcription Billing, Corp. and changed its name to MTBC, Inc. in February 2019. MTBC, Inc. was founded in 1999 and is headquartered in Somerset, New Jersey.

Details
Name: MTBC, Inc.
MTBC
Exchange: NasdaqGM
Founded: 1999
$61,223,751
12,028,242
Website: http://www.mtbc.com
Address: MTBC, Inc.
7 Clyde Road,
Somerset,
New Jersey, 08873,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NasdaqGM MTBC Common Shares Nasdaq Global Market US USD 23. Jul 2014
DB MTB Common Shares Deutsche Boerse AG DE EUR 23. Jul 2014
NasdaqGM MTBC.P 11% CUM PFD CL A Nasdaq Global Market US USD 05. Nov 2015
Number of employees
Current staff
Staff numbers
2,400
MTBC employees.
Industry
Health Care Technology
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/05/23 06:27
End of day share price update: 2019/05/22 00:00
Last estimates confirmation: 2019/05/13
Last earnings filing: 2019/05/08
Last earnings reported: 2019/03/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.